Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF
Bone Marrow Transplantation. 2005;36(8):663-666.Abstract
Healthy stem cell donors start leukapheresis 4 -5 days after starting G-CSF based on the peripheral blood CD34+ cell count (PBCD34). Data from 137 harvests (68 donors) were analyzed to determine correlation between pre-apheresis leukocytes (11.0-94.8 × 10 9/l; median 38.8) and platelets (49-374 × 10 9/l; median 180), and PBCD34 (3 -276/μl; median 40). PBCD34 correlated positively with leukocytes (r=0.48; P<0.0001) and platelets (r=0.40; P<0.0001). When pre-apheresis leukocytes were ≥25 and platelets were ≥100, PBCD34 and CD34+ collection were 5-276/μl (median 57) and 0.5-27.6 × 10 6/kg (median 4.7), respectively; significantly higher than PBCD34 of 3-74/μl (median 17) and CD34+ collection of 0.2-8.9 × 10 6/kg (median 2.2) when leukocytes were <25 and/or platelets were <100. With leukocytes ≥25 and platelets ≥100, PBCD34 was low (<20/μl) 8% of the time, compared to 57% of the time with leukocytes <25 and/or platelets <100 (P<0.0001). Our data suggest that it is not always necessary to measure PBCD34 to guide leukapheresis in healthy donors because pre-apheresis leukocytes and platelets ≥25 and ≥100, respectively, are associated with excellent mobilization. When blood counts do not meet these criteria, PBCD34 should be determined prior to initiation of apheresis. © 2005 Nature Publishing Group. All rights reserved.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
A. Gidron; A. Verma; M. Doyle; L. Boggio; A. Evens; L. Gordon; S. Singhal; M. Tallman; S. Wlliams; J. Winter; et al.Bone Marrow Transplantation. 2005;35(3):243-246.
L. Statkute; L. Verda; Y. Oyama; A. Traynor; M. Villa; T. Shook; R. Clifton; B. Jovanovic; J. Satkus; et al.Bone Marrow Transplantation. 2007;39(6):317-329.
Todd M. Zimmerman; Glenn C. Michelson; Rosemarie Mick; David L. Grinblatt; Stephanie F. WilliamsJournal of Clinical Apheresis. 1999;14(1):31-34.
Appears in this Document